We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Accenture (ACN) Announces Completion of OpusLine Buyout
Read MoreHide Full Article
Accenture plc (ACN - Free Report) announced yesterday that it has completed the acquisition of OpusLine, a move that was announced on Oct 27. Financial terms of the transaction were kept under wraps.
Established in 2012, OpusLine is one of the largest independent health consulting companies in France. The company, with more than 85 highly qualified consultants, has united with the new Health practice of Accenture Strategy & Consulting in France.
How Will Accenture Benefit?
Accenture should benefit from OpusLine’s experience in providing strategic advisory and transformational services to public- and private-sector healthcare providers, and life sciences and insurance companies.
The buyout will enhance Accenture as a provider of latest innovations in data analytics, artificial intelligence, robotics and internet of things areas to its clients across health, life sciences and insurance industries. This in turn should enable clients convey digital innovation across their organizations.
Over the past year, shares of Accenture have gained 26.4%, ahead of 21.5% growth of the industry it belongs to and 16.7% rally of the Zacks S&P 500 composite.
Zacks Rank and Stocks to Consider
Accenture currently carries a Zacks Rank #3 (Hold).
Long-term earnings (three to five years) growth rate for Republic Services, Gartner and Insperity is estimated at 9.4%, 13.5% and 15%, respectively.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Image: Bigstock
Accenture (ACN) Announces Completion of OpusLine Buyout
Accenture plc (ACN - Free Report) announced yesterday that it has completed the acquisition of OpusLine, a move that was announced on Oct 27. Financial terms of the transaction were kept under wraps.
Established in 2012, OpusLine is one of the largest independent health consulting companies in France. The company, with more than 85 highly qualified consultants, has united with the new Health practice of Accenture Strategy & Consulting in France.
How Will Accenture Benefit?
Accenture should benefit from OpusLine’s experience in providing strategic advisory and transformational services to public- and private-sector healthcare providers, and life sciences and insurance companies.
The buyout will enhance Accenture as a provider of latest innovations in data analytics, artificial intelligence, robotics and internet of things areas to its clients across health, life sciences and insurance industries. This in turn should enable clients convey digital innovation across their organizations.
Over the past year, shares of Accenture have gained 26.4%, ahead of 21.5% growth of the industry it belongs to and 16.7% rally of the Zacks S&P 500 composite.
Zacks Rank and Stocks to Consider
Accenture currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Business Services sector are Republic Services (RSG - Free Report) , Gartner (IT - Free Report) and Insperity (NSP - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1(Strong Buy) Rank stocks here.
Long-term earnings (three to five years) growth rate for Republic Services, Gartner and Insperity is estimated at 9.4%, 13.5% and 15%, respectively.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>